CIK 0001156039 · Large accelerated filer
Elevance Health, Inc.
Sign in to watch- Ticker
- ELV
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- operating
- EIN
- 352145715
- Phone
- 8003311476
- Business address
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
- Former names
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,230,357
- in 2 filings
Net −$5,230,357. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Norwood Felicia F EVP & President,Gov Health Ben | Grant or award | +3,035 | 27,726 | ||
| 2025-03-03 | Norwood Felicia F EVP & President,Gov Health Ben | Grant or award | +4,213 | 31,939 | ||
| 2025-03-03 | Norwood Felicia F EVP & President,Gov Health Ben | Grant or award · Employee Stock Option (Right to Buy) | +11,549 | 11,549 | ||
| 2025-03-03 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Shares withheld for taxes | −2,281 | $395.50 | $902K | 18,756 |
| 2025-03-03 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award | +3,035 | 21,791 | ||
| 2025-03-03 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award | +4,213 | 26,004 | ||
| 2025-03-03 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award · Employee Stock Option (Right to Buy) | +11,549 | 11,549 | ||
| 2025-03-03 | Kaye Mark EVP & CFO | Shares withheld for taxes | −270 | $395.50 | $107K | 19,961 |
| 2025-03-03 | Kaye Mark EVP & CFO | Grant or award | +3,604 | 23,565 | ||
| 2025-03-03 | Kaye Mark EVP & CFO | Grant or award · Employee Stock Option (Right to Buy) | +13,713 | 13,713 | ||
| 2025-03-03 | BOUDREAUX GAIL President and CEO | Shares withheld for taxes | −10,396 | $395.50 | $4.1M | 116,313 |
| 2025-03-03 | BOUDREAUX GAIL President and CEO | Grant or award | +10,620 | 126,933 | ||
| 2025-03-03 | BOUDREAUX GAIL President and CEO | Grant or award | +15,587 | 142,520 | ||
| 2025-03-03 | BOUDREAUX GAIL President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +40,429 | 40,429 | ||
| 2025-01-03 | Todt Blair Williams EVP, CLO & CAO | Shares withheld for taxes | −398 | $371.56 | $148K | 15,631 |
| 2024-11-01 | Kendrick Charles Morgan JR EVP & President, Commercial | Shares withheld for taxes | −846 | $414.01 | $350K | 7,577 |
| 2024-11-01 | Kendrick Charles Morgan JR EVP & President, Commercial | Grant or award | +1,710 | 9,287 | ||
| 2024-11-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Shares withheld for taxes | −1,649 | $414.01 | $683K | 17,238 |
| 2024-11-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award | +3,799 | 21,037 | ||
| 2024-10-18 | Kendrick Charles Morgan JR EVP & President, Commercial | Sale | −7,417 | $432.14 | $3.2M | 8,423 |
Page 7 of 26 · 514 trades